The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning insulin is only released when blood glucose levels are elevated Suppressing glucagon release from pancreatic alpha cells, which reduces hepatic glucose production Slowing gastric emptying , which helps moderate post-meal blood glucose spikes Reducing appetite through central nervous system effects, leading to decreased caloric intake and weight loss Examples of GLP-1 receptor agonists available in the UK include exenatide (Byetta, Bydureon), liraglutide (Victoza for diabetes, Saxenda for weight management), dulaglutide (Trulicity), lixisenatide (Lyxumia), and semaglutide (Ozempic/Rybelsus for diabetes, Wegovy for weight management)

Ozempic may cause diabetic retinopathy Semaglutide, the active ingredient in Ozempic, may increase the risk of early worsening of diabetic retinopathy (damage to the retina of the eye), particularly in people who already have this eye condition
Healthcare professionals should monitor the growth of children and adolescents during treatment with Adderall, and treatment should be interrupted in children who are not growing or gaining weight as expected
Potential Benefits Associated with Tirzepatide Blood sugar control Diabetes is characterized by elevated blood sugar levels
Some foods can trigger unpleasant side effects, like nausea, or make it hard to get all the nutrients you need on a reduced appetite